These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 26858388

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016-2018.
    Brown KE, Rota PA, Goodson JL, Williams D, Abernathy E, Takeda M, Mulders MN.
    MMWR Morb Mortal Wkly Rep; 2019 Jul 05; 68(26):587-591. PubMed ID: 31269012
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Measles elimination programme on the world and Poland].
    Makówka A, Gut W, Litwińska B.
    Przegl Epidemiol; 2007 Jul 05; 61(1):135-42. PubMed ID: 17702452
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Perspectives on the role of surveillance in eliminating rubella and congenital rubella syndrome in the Americas.
    Andrus JK, de Quadros CA.
    Expert Rev Vaccines; 2013 Sep 05; 12(9):989-93. PubMed ID: 24053393
    [Abstract] [Full Text] [Related]

  • 50. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].
    Wichmann O, Ultsch B.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep 05; 56(9):1260-9. PubMed ID: 23990088
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Elimination of measles and rubella in Germany: Progress and hindrances].
    Pfaff G.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep 05; 56(9):1222-4. PubMed ID: 23990082
    [No Abstract] [Full Text] [Related]

  • 54. Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.
    Winter AK, Lambert B, Klein D, Klepac P, Papadopoulos T, Truelove S, Burgess C, Santos H, Knapp JK, Reef SE, Kayembe LK, Shendale S, Kretsinger K, Lessler J, Vynnycky E, McCarthy K, Ferrari M, Jit M.
    Lancet Glob Health; 2022 Oct 05; 10(10):e1412-e1422. PubMed ID: 36113527
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. National, Regional and Global Certification Bodies for Polio Eradication: A Framework for Verifying Measles Elimination.
    Deblina Datta S, Tangermann RH, Reef S, William Schluter W, Adams A.
    J Infect Dis; 2017 Jul 01; 216(suppl_1):S351-S354. PubMed ID: 28838172
    [Abstract] [Full Text] [Related]

  • 60. [Molecular surveillance shows progress in measles elimination process].
    Santibanez S, Mankertz A.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep 01; 56(9):1238-42. PubMed ID: 23990085
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.